Study guide
12.4 Impairment: The Expected Credit Loss (ECL) Model
CPA Program — Financial Reporting Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The Reporting Environment & Conceptual Framework
1.1 General Purpose Financial Reporting & The International Environment 1.2 Qualitative Characteristics & Elements of Financial Statements 1.3 Recognition, Derecognition & Measurement Bases
2 Chapter 2: Measurement Applications & Professional Judgement
2.1 Measurement Applications Across IFRS Standards 2.2 Materiality & Professional Judgement in Reporting 2.3 Exam Strategy & The CPA Financial Reporting Open-Book Architecture
3 Chapter 3: Primary Financial Statements & IAS 1 Presentation
3.1 IAS 1 Presentation Foundations & Statement of Financial Position 3.2 Statement of Profit or Loss and Other Comprehensive Income 3.3 Statement of Changes in Equity & Note Disclosures 3.4 IAS 7 Statement of Cash Flows
4 Chapter 4: Accounting Policies, Estimates, Post-Balance Date Events & Segments
4.1 IAS 8 Accounting Policies, Changes in Accounting Estimates and Errors 4.2 IAS 10 Events After the Reporting Period 4.3 IFRS 8 Operating Segments & IAS 34 Interim Financial Reporting
5 Chapter 5: IFRS 15 Revenue from Contracts with Customers
5.1 The Five-Step Revenue Model: Steps 1 to 3 5.2 The Five-Step Revenue Model: Steps 4 & 5 5.3 Specific IFRS 15 Applications, Contract Costs & Disclosures
6 Chapter 6: IAS 37 Provisions, Contingent Liabilities & Contingent Assets
6.1 Provisions Recognition Criteria & Measurement 6.2 Specific Provision Applications 6.3 Contingent Liabilities & Contingent Assets
7 Chapter 7: Fundamentals of Income Taxes & Temporary Differences
7.1 IAS 12 Balance Sheet Liability Method & Current Tax 7.2 Tax Bases of Assets & Liabilities 7.3 Taxable Temporary Differences & Deferred Tax Liabilities 7.4 Deductible Temporary Differences & Deferred Tax Assets
8 Chapter 8: Deferred Tax Advanced Applications, Revaluations & Disclosures
8.1 Initial Recognition Exemption & Recent Amendments 8.2 Deferred Tax on Revalued Assets & OCI/Equity Items 8.3 Measurement Principles & Strict Prohibition on Discounting 8.4 Financial Statement Presentation, Disclosures & Tax Reconciliation
9 Chapter 9: IFRS 3 Business Combinations & The Acquisition Method
9.1 Scope of IFRS 3 & Identifying a Business Combination 9.2 Acquisition Date & Consideration Transferred 9.3 Recognising & Measuring Identifiable Net Assets & NCI 9.4 Goodwill & Gain on Bargain Purchase
10 Chapter 10: IFRS 10 Consolidation Principles & Elimination Mechanics
10.1 IFRS 10 Control Model & Consolidation Procedures 10.2 Acquisition Analysis & Business Combination Valuation Entries 10.3 Intragroup Balances & Transactions Elimination 10.4 Unrealised Profits in Intragroup Asset Transfers
11 Chapter 11: Associates, Joint Arrangements & Group Disclosures
11.1 IAS 28 Investments in Associates & The Equity Method 11.2 IFRS 11 Joint Arrangements 11.3 Group Reporting Disclosures & Changes in Ownership
12 Chapter 12: Classification, Measurement & Impairment of Financial Instruments
12.1 Financial Instrument Definitions & Scope 12.2 Classification & Measurement of Financial Assets 12.3 Classification & Measurement of Financial Liabilities & Derecognition 12.4 Impairment: The Expected Credit Loss (ECL) Model
13 Chapter 13: Presentation, Compound Instruments & Hedge Accounting
13.1 IAS 32 Presentation: Debt vs Equity Classification 13.2 Compound Financial Instruments & Split Accounting 13.3 IFRS 9 Hedge Accounting & IFRS 7 Risk Disclosures
14 Chapter 14: IAS 36 Foundations & Impairment of Individual Assets
14.1 Scope of IAS 36 & Indicators of Impairment 14.2 Recoverable Amount: FVLCD vs Value in Use 14.3 Impairment Testing & Accounting for Individual Assets
15 Chapter 15: Cash-Generating Units, Goodwill & Impairment Reversals
15.1 Identification & Impairment of Cash-Generating Units (CGUs) 15.2 Goodwill Impairment & Allocation of Losses 15.3 Impairment Reversals & Mandatory Annual Testing
12.4 Impairment: The Expected Credit Loss (ECL) Model
Key Takeaways Explain This Topic AI
IFRS 9 replaced the retrospective IAS 39 incurred loss model with a forward-looking Expected Credit Loss (ECL) model, eliminating the procyclical delay in recognizing credit impairment.
The ECL model applies to debt instruments measured at amortised cost or FVOCI, lease receivables, contract assets, loan commitments, and financial guarantee contracts, but never to equity investments.
The General 3-Stage Model transitions assets from Stage 1 (12-month ECL, gross interest) to Stage 2 (lifetime ECL, gross interest) upon a Significant Increase in Credit Risk (SICR), and to Stage 3 (lifetime ECL, net interest) when credit-impaired.
The 30 days past due rebuttable presumption serves as a backstop indicator of SICR under Stage 2, while 90 days past due indicates default and credit impairment under Stage 3.
The Simplified Approach mandates lifetime ECL from initial recognition for trade receivables and contract assets without a significant financing component, typically operationalised via a Provision Matrix.
Last updated: October 2026
12.4 Impairment: The Expected Credit Loss (ECL) Model
Core Principle: Under IFRS 9, an entity does not wait for a credit loss event to occur before recognizing impairment. Credit risk is factored into financial statements from day one, recognizing a 12-month expected credit loss upon acquisition and scaling to lifetime expected losses as soon as credit risk increases significantly.
The global financial crisis of 2008 exposed fatal weaknesses in the historical accounting standards. Under IAS 39 , an entity could only recognize an impairment loss if there was objective evidence of an incurred loss event (such as missed loan installments or a borrower declaring bankruptcy). This backward-looking framework resulted in provisions being recognized "too little, too late", exacerbating the banking crisis. IFRS 9 replaced this with a forward-looking Expected Credit Loss (ECL) model.
1. Scope of the IFRS 9 ECL Model
Under paragraph 5.5.1 of IFRS 9, the impairment model applies to:
- Financial assets measured at Amortised Cost (e.g. trade receivables, commercial loans, held debt securities);
- Debt instruments measured at Fair Value through Other Comprehensive Income (FVOCI) ;
- Lease receivables within the scope of IFRS 16;
- Contract assets within the scope of IFRS 15;
- Loan commitments issued where there is a present legal obligation to extend credit; and
Financial guarantee contracts issued by an entity.
Exam Rule — Equity Exclusion: The IFRS 9 impairment model never applies to equity investments . Equity instruments are measured either at FVTPL (where impairment is inherently reflected in fair value in profit or loss) or at FVOCI (where fair value movements sit in equity and are exempt from impairment testing under IFRS 9.5.7.5).
2. The General 3-Stage Model
For financial assets within scope, IFRS 9 establishes a dynamic three-stage framework reflecting changes in credit quality since initial recognition:
Feature Stage 1: Performing Stage 2: Underperforming Stage 3: Credit-Impaired
Credit Status No significant increase in credit risk since initial recognition Significant Increase in Credit Risk (SICR) since initial recognition Objective evidence of impairment ( Default event occurred )
Loss Allowance 12-Month ECL (portion of lifetime ECL from defaults in next 12 months) Lifetime ECL (expected losses over entire remaining life) Lifetime ECL (expected losses over entire remaining life)
Interest Revenue Basis Gross Carrying Amount × \times × EIR Gross Carrying Amount × \times × EIR Net Carrying Amount (Gross CA less Allowance) × \times × EIR
Backstop Presumption Current / < 30 days past due ≥ 30 days past due \mathbf{\ge 30\text{ days past due}} ≥ 30 days past due (rebuttable) ≥ 90 days past due \mathbf{\ge 90\text{ days past due}} ≥ 90 days past due (rebuttable)
Loading diagram... IFRS 9 Three-Stage ECL Staging Architecture & Transition Rules
What Constitutes a Significant Increase in Credit Risk (SICR)?
A critical requirement of Stage 2 is that the assessment of SICR is a relative test, not an absolute test :
The entity evaluates whether the default risk at the reporting date has increased significantly compared to the default risk estimated at initial recognition .
An asset that was already sub-prime at initial recognition does not move to Stage 2 unless its default risk has worsened relative to that sub-prime baseline.
Indicators of SICR:
Significant internal or external credit rating downgrades (e.g. moving from investment grade BBB to speculative grade B).
Adverse changes in commercial, financial, or macroeconomic conditions that affect the borrower's repayment capacity (e.g. sharp rise in benchmark interest rates or industry recession).
Breach of contractual covenants or debt restructuring requests.
Rebuttable 30-Day Presumption (IFRS 9.5.5.11): Contractual payments more than 30 days past due create a rebuttable presumption of SICR, moving the asset from Stage 1 to Stage 2.
The "Low Credit Risk" Operational Expedient
Under paragraph 5.5.10 of IFRS 9, if a financial asset has low credit risk at the reporting date (e.g. an external 'investment grade' rating of BBB- or higher from Standard & Poor's / Fitch, or Baa3 from Moody's), the entity is permitted to assume that credit risk has not increased significantly since initial recognition, maintaining the asset in Stage 1 .
The Shift in Interest Revenue: Gross vs Net Carrying Amount
Candidates must master the exact calculation of interest income across the three stages:
In Stages 1 and 2: The asset is not credit-impaired. Interest revenue is calculated by applying the effective interest rate to the Gross Carrying Amount of the asset (ignoring the loss allowance): Interest Revenue (Stages 1 & 2) = Gross Carrying Amount × EIR \text{Interest Revenue (Stages 1 \& 2)} = \text{Gross Carrying Amount} \times \text{EIR} Interest Revenue (Stages 1 & 2) = Gross Carrying Amount × EIR
In Stage 3: The asset is credit-impaired. It is inappropriate to recognize interest income on contractual balances that the entity does not expect to recover. Therefore, interest revenue is calculated by applying the effective interest rate to the Net Carrying Amount (Gross carrying amount less the lifetime loss allowance): Interest Revenue (Stage 3) = ( Gross Carrying Amount − Loss Allowance ) × EIR \text{Interest Revenue (Stage 3)} = (\text{Gross Carrying Amount} - \text{Loss Allowance}) \times \text{EIR} Interest Revenue (Stage 3) = ( Gross Carrying Amount − Loss Allowance ) × EIR
Symmetry and Curing: Staging is symmetrical. If an economic recovery or successful borrower turnaround resolves the credit impairment in a subsequent period, the asset "cures" and transitions back from Stage 3 to Stage 2, or Stage 2 to Stage 1, restoring gross interest calculation.
3. Balance Sheet Presentation: Amortised Cost vs FVOCI Debt
A common CPA exam question tests the bookkeeping divergence for ECL between Amortised Cost assets and FVOCI debt assets:
Financial Assets at Amortised Cost
The loss allowance is presented on the balance sheet as a direct contra-asset account reducing the gross asset: Dr Impairment Loss (Profit or Loss) $X Cr Loss Allowance (Contra-Asset on Balance Sheet) $X \begin{aligned}
- \textbf{Dr} & \quad \text{Impairment Loss (Profit or Loss)} & \text{\$X} & \\
- \textbf{Cr} & \quad \text{Loss Allowance (Contra-Asset on Balance Sheet)} & & \text{\$X}
\end{aligned} Dr Cr Impairment Loss (Profit or Loss) Loss Allowance (Contra-Asset on Balance Sheet) $X $X
Debt Instruments at FVOCI
Under IFRS 9.5.5.16, because the debt instrument is already carried at fair value on the Statement of Financial Position, the loss allowance cannot reduce the asset's carrying amount ! Doing so would double-count the impairment reduction. Instead, the loss allowance is recognized in Other Comprehensive Income : Dr Impairment Loss (Profit or Loss) $X Cr Other Comprehensive Income (FVOCI Reserve) $X \begin{aligned}
- \textbf{Dr} & \quad \text{Impairment Loss (Profit or Loss)} & \text{\$X} & \\
- \textbf{Cr} & \quad \text{Other Comprehensive Income (FVOCI Reserve)} & & \text{\$X}
- \end{aligned} Dr Cr Impairment Loss (Profit or Loss) Other Comprehensive Income (FVOCI Reserve) $X $X
The carrying amount on the balance sheet remains the actual market fair value; the credit in OCI ensures that profit or loss reflects the exact same impairment expense as if the asset were measured at amortised cost.
4. The Simplified Approach for Trade Receivables (IFRS 9.5.5.15)
Tracking whether credit risk has increased significantly since inception for thousands of short-term invoices would be practically impossible for commercial operating entities. Consequently, IFRS 9 provides the Simplified Approach :
Mandatory Application: Trade receivables and contract assets that do not contain a significant financing component under IFRS 15.
Accounting Policy Choice: Trade receivables and contract assets that do contain a significant financing component, and all lease receivables under IFRS 16.
Core Rules of the Simplified Approach
The entity does not monitor SICR or stage migrations.
The loss allowance is measured at an amount equal to Lifetime ECL from day one (initial recognition) until final settlement.
Entities routinely operationalise this requirement using a Provision Matrix .
Constructing a Provision Matrix
A provision matrix segments trade receivables into aging categories (e.g. Current, 1–30 days past due, 31–60 days past due, 61–90 days past due, >90 days past due) and applies historical default loss rates adjusted for forward-looking macroeconomic data .
- 5. Comprehensive Worked Scenarios
- Scenario A: General 3-Stage Model Transition & Interest Calculations
On 1 July 2024, Austral Finance Ltd issued a 4-year commercial loan of $10,000,000 to Horizon Logistics. The contractual interest rate is 8.0% per annum , payable annually on 30 June. There were no transaction costs (EIR = 8.0%).
Year 1 (Ended 30 June 2025) — Stage 1 (Performing)
Horizon pays the $800,000 coupon on time.
At 30 June 2025, credit risk is low. Austral estimates 12-month ECL at $100,000 . Interest Revenue (P/L) = $ 10 , 000 , 000 × 8 % = $ 800 , 000 Impairment Expense (P/L) = $ 100 , 000 Statement of Financial Position = Gross Loan $ 10 , 000 , 000 − Allowance $ 100 , 000 = $ 9 , 900 , 000 \begin{aligned}
- \text{Interest Revenue (P/L)} &= \$10,000,000 \times 8\% = \mathbf{\$800,000} \\
- \text{Impairment Expense (P/L)} &= \mathbf{\$100,000} \\
\text{Statement of Financial Position} &= \text{Gross Loan } \$10,000,000 - \text{Allowance } \$100,000 = \mathbf{\$9,900,000}
\end{aligned} Interest Revenue (P/L) Impairment Expense (P/L) Statement of Financial Position = $10 , 000 , 000 × 8% = $800 , 000 = $100 , 000 = Gross Loan $10 , 000 , 000 − Allowance $100 , 000 = $9 , 900 , 000
Year 2 (Ended 30 June 2026) — Stage 2 (Underperforming / SICR)
Horizon experiences a major contract loss and misses interest payment deadlines; payments are 45 days overdue at 30 June 2026. Austral determines that a Significant Increase in Credit Risk (SICR) has occurred.
The loan moves to Stage 2 . Austral calculates Lifetime ECL at $750,000 .
Crucially, because the loan is in Stage 2 (not credit-impaired), interest revenue is still calculated on the Gross Carrying Amount of $10,000,000: Interest Revenue (P/L) = $ 10 , 000 , 000 × 8 % = $ 800 , 000 Additional Impairment Expense (P/L) = $ 750 , 000 − $ 100 , 000 = $ 650 , 000 Statement of Financial Position = Gross Loan $ 10 , 800 , 000 − Allowance $ 750 , 000 = $ 10 , 050 , 000 \begin{aligned}
- \text{Interest Revenue (P/L)} &= \$10,000,000 \times 8\% = \mathbf{\$800,000} \\
- \text{Additional Impairment Expense (P/L)} &= \$750,000 - \$100,000 = \mathbf{\$650,000} \\
\text{Statement of Financial Position} &= \text{Gross Loan } \$10,800,000 - \text{Allowance } \$750,000 = \mathbf{\$10,050,000}
\end{aligned} Interest Revenue (P/L) Additional Impairment Expense (P/L) Statement of Financial Position = $10 , 000 , 000 × 8% = $800 , 000 = $750 , 000 − $100 , 000 = $650 , 000 = Gross Loan $10 , 800 , 000 − Allowance $750 , 000 = $10 , 050 , 000
Year 3 (Ended 30 June 2027) — Stage 3 (Credit-Impaired)
On 1 July 2026 (start of Year 3), Horizon enters formal voluntary administration. The loan is formally classified as credit-impaired (Stage 3) .
Gross loan balance at 1 July 2026: $10,800,000. Loss allowance: $750,000. Net carrying amount: $10,050,000 .
During Year 3, Austral revises its recovery estimate, increasing the lifetime loss allowance to $2,500,000 at 30 June 2027.
Interest Revenue Calculation in Stage 3: Interest is calculated on the Net Carrying Amount at the start of the period: Interest Revenue (Year 3) = ( $ 10 , 800 , 000 − $ 750 , 000 ) × 8 % = $ 10 , 050 , 000 × 8 % = $ 804 , 000 \text{Interest Revenue (Year 3)} = (\$10,800,000 - \$750,000) \times 8\% = \$10,050,000 \times 8\% = \mathbf{\$804,000} Interest Revenue (Year 3) = ( $10 , 800 , 000 − $750 , 000 ) × 8% = $10 , 050 , 000 × 8% = $804 , 000
(Notice that in Stage 3, interest revenue is $804,000 rather than $864,000 [$10,800,000 × \times × 8%], reflecting the net interest basis).
Scenario B: Simplified Approach using a Provision Matrix
At 30 June 2026, Apex Commercial Ltd holds a trade receivables ledger of $12,500,000 arising from sales with 30-day payment terms (no financing component). The loss allowance at 1 July 2025 was $320,000 .
Apex calculates historical default rates from the past 3 years. Due to an economic slowdown and rising commercial interest rates, management applies a forward-looking macroeconomic multiplier of 1.25 ( + 25 % +25\% + 25% ) to its historical default rates:
Aging Category Gross Carrying Amount Historical Default Rate Forward-Looking Rate ( 1.25 × 1.25 \times 1.25 × ) Lifetime ECL Allowance
- Current (0–30 days) $7,500,000 1.0% 1.25% $93,750
- 1–30 days past due $2,800,000 2.4% 3.00% $84,000
- 31–60 days past due $1,200,000 6.0% 7.50% $90,000
- 61–90 days past due $600,000 16.0% 20.00% $120,000
- >90 days past due $400,000 50.0% 62.50% $250,000
- Total $12,500,000 $637,750
Accounting Journal Entry at 30 June 2026: Required Ending Allowance $ 637 , 750 Existing Opening Allowance ( $ 320 , 000 ) Impairment Loss for Year (P/L) $ 317 , 750 \begin{aligned}
- \text{Required Ending Allowance} & \quad \$637,750 \\
- \text{Existing Opening Allowance} & \quad (\$320,000) \\
- \textbf{Impairment Loss for Year (P/L)} & \quad \mathbf{\$317,750}
\end{aligned} Required Ending Allowance Existing Opening Allowance Impairment Loss for Year (P/L) $637 , 750 ( $320 , 000 ) $317 , 750 Dr Impairment Loss on Receivables (Profit or Loss) $ 317 , 750 Cr Loss Allowance (Statement of Financial Position) $ 317 , 750 \begin{aligned}
- \textbf{Dr} & \quad \text{Impairment Loss on Receivables (Profit or Loss)} & \$317,750 & \\
- \textbf{Cr} & \quad \text{Loss Allowance (Statement of Financial Position)} & & \$317,750
\end{aligned} Dr Cr Impairment Loss on Receivables (Profit or Loss) Loss Allowance (Statement of Financial Position) $317 , 750 $317 , 750
(Trade receivables are presented on the balance sheet at a net carrying amount of $12,500,000 - $637,750 = $11,862,250 ).